Fundraising Fox
/Companies
Sign in

Sonablate

Charlotte, US · Founded 2021 · Delaware corporation · 1 known investors

Find your way into Sonablate

Sign up to see every warm intro you have to Sonablate

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sonablate team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Sonablate Corp. develops HIFU (high-intensity focused ultrasound) technology for focal therapy, initially applied to treating prostate disease as an alternative to conventional treatments. Its systems are used by physicians, with plans to address a broader range of medical conditions.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

TM
Thomas MendellNamed on SEC filing
RS
Ralph SeipNamed on SEC filing
LT
Louis TaNamed on SEC filing
RY
Richard YangNamed on SEC filing
HW
Hong WeiNamed on SEC filing
NS
Neal SanganiNamed on SEC filing
AG
Alejandro GonzalezNamed on SEC filing
BM
Bruce MurphyNamed on SEC filing
SP
Samuel PeretsmanNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$377K disclosed across 1 of 2 rounds · 2023–2026

▶$377KraisedAug 2023 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas MendellDirector
  • Ralph SeipExecutive Officer
  • Louis TaExecutive Officer
  • Richard YangExecutive Officer, Director
  • Hong WeiDirector
  • Neal SanganiDirector
  • Alejandro GonzalezExecutive Officer, Director
  • Bruce MurphyDirector
  • Samuel PeretsmanDirector
Offering amount
$60M
Amount sold
$377K
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Sonablate do?
Sonablate Corp. develops HIFU (high-intensity focused ultrasound) technology for focal therapy, initially applied to treating prostate disease as an alternative to conventional treatments. Its systems are used by physicians, with plans to address a broader range of medical conditions.
Who are Sonablate's investors?
Sonablate's investors include 8VC.
How much funding has Sonablate raised?
Sonablate has disclosed $377K raised across 1 of its 2 known rounds.
Where is Sonablate headquartered?
Sonablate is headquartered in Charlotte, US.